A Study in Patients With Mixed Dyslipidemia
NCT06497127
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
145
Enrollment
INDUSTRY
Sponsor class
Conditions
Mixed Dyslipidemia
Interventions
DRUG:
BW-00112
Sponsor
Shanghai Argo Biopharmaceutical Co., Ltd.